The development of GLP-1 medicines has transformed the therapeutic options for patients with type 2 diabetes (T2D) who are unable to achieve sufficient glucose control with existing treatments
We also provide ongoing support and education so you understand not just how GLP-1 works, but how to make it work best for your body
Obesity changes your muscle 'engine type': Excess weight shifts muscle fiber composition, reducing efficient, fat-burning Type I fibers and increasing less efficient, fatigue-prone Type IIx fibers, worsening metabolic flexibility
If Wegovy does not produce a clinically meaningful weight loss after an appropriate trial at the maintenance dose, your healthcare provider may recommend reviewing or discontinuing treatment and discussing alternative weight management options
The Core Difference: One Peptide The structural difference between GLOW and KLOW is straightforward: GLOW Blend (70mg total): GHK-Cu (50mg) BPC-157 (10mg) TB-500 (10mg) KLOW Blend (80mg total): KPV GHK-Cu BPC-157 TB-500 KLOW retains all three GLOW peptides and adds KPV as the fourth component